Patients undergoing surgical aortic-valve replacement (SAVR) following problems with an initial transcatheter aortic-valve replacement (TAVR) appear to have particularly poor outcomes, according to a retrospective analysis.
As Dr. Oliver K. Jawitz told Reuters Health by email, “SAVR after early failure of TAVR devices appears to be a complex, technically demanding procedure associated with long operative times, increased perioperative morbidity, and higher than expected operative mortality.”
In a paper in JACC: Cardiovascular Interventions, Dr. Jawitz of Duke University School of Medicine, in Durham, North Carolina, and colleagues observe that as TAVR grows more popular, management of device failure will become increasingly important. “However,” they say, “the outcomes of re-operation for TAVR failure are unknown.”
Out of about 40,000 TAVR procedures in the Society of Thoracic Surgeons Adult Cardiac Surgery Database, the researchers identified 123 patients with a history of prior TAVR who underwent SAVR between 2011 and 2015.

